Thank you to contributors (13 December, 2017)
Drug and Therapeutics Bulletin provides rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. The journals aim is to provide informed and unbiased information on medical conditions, medicines and other treatments to enable readers to make informed choices and ensure patients get the best care.
Drug and Therapeutics Bulletin is wholly independent of the pharmaceutical industry, Government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.
Shared care protocols – have they had their day? (6 December, 2017)
Bazedoxifene for HRT? (13 April, 2017)
Lidocaine/prilocaine spray for premature ejaculation (13 April, 2017)
An update on the bleeding risks associated with DOACs (8 November, 2017)
Prescribing in pregnancy – stop stopping and start planning (31 October, 2017)
Prescribing PPIs (11 October, 2017)
Naltrexone/bupropion for obesity (8 November, 2017)
Rivaroxaban plus aspirin for secondary prevention (31 October, 2017)